Skip to main content

Table 3 Results of initial LFT for viral hepatitis cases using laboratory-specific criteria for abnormality

From: Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort

 

Case No.

ALT

AST

Bilirubin

ALP

GGT

Albumin

Globulin

Total Protein

Repeat LFT

Country of Origin (prevalence of viral hepatitis)

HBV

1

High*

High

Normal

Normal

High

Normal

Normal

High

Abnormal

Kenya (High)

 

2

Normal

Normal

High

Normal

Normal

High

Low

Normal

Abnormal

UK (Low)

 

3

High

Normal

Normal

Normal

High

Normal

Normal

Normal

Abnormal

Pakistan (High)

 

4

High*

High

High

Normal

High

Normal

Normal

High

Abnormal

India (High)

 

5

High*

High

Normal

Normal

Normal

Normal

Normal

Normal

Abnormal

Malaysia (High)

 

6

High*

No result

No result

No result

Normal

Normal

Normal

Normal

Abnormal

UK (Low)

 

7

Normal

Normal

Normal

Normal

Normal

Normal

High

High

Abnormal

Kenya (High)

 

8

No result

High

Normal

High

No result

Normal

No result

No result

Abnormal

Iraq (High)

 

9

Normal

No result

High

Normal

No result

Normal

No result

No result

Incomplete**

Malta (High)

HCV

1

High

Normal

Normal

Normal

High

Normal

Normal

Normal

Incomplete

Pakistan (High)

 

2

High*

High

Normal

Normal

Normal

Normal

Normal

High

Abnormal

Hong Kong (High)

 

3

Normal

No result

Normal

Normal

High

Normal

No result

No result

Abnormal

Jamaica (High)

 

4

High*

High

Normal

Normal

Normal

Normal

Normal

Normal

Abnormal

Somalia (High)

  1. * Denotes where ALT values were greater than twice the upper limit of normal.
  2. ** Repeat test available for AST and GGT only, both of which were normal.
  3. ALT: Alanine aminotransferase;
  4. AST: Aspartate aminotransferase;
  5. ALP: Alkaline phosphatase;
  6. GGT: Gamma-glutamyltransferase;
  7. HBV: Hepatitis B;
  8. HCV: Hepatitis C.